Clinical Trial Update: A Trial Evaluating Surufatinib Efficacy and Safety in Biliary Tract Carcinoma Patients [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update discusses evaluating surufatinib for biliary tract cancer across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Surufatinib (Surufatinib)

Snippet

Sponsor: Hutchison Medipharma Limited | Conditions: Biliary Tract Cancer | Phase 2, Phase 3 | Status: UNKNOWN